She serves as the Director of the UCSF Vasculitis Clinic, a tertiary referral center for patients with systemic vasculitides in the western United States. The goal of her research program is to discover genomic factors that influence autoimmune disease susceptibility and activity, in order to identify biologic pathways involved in disease pathogenesis and potential targets for therapeutic intervention. Current projects include integrative studies of genetic, epigenetic, and transcriptional variation in granulomatosis with polyangiitis (Wegener’s) disease susceptibility and activity. Dr. Chung is a member of the Vasculitis Clinical Research Consortium, an international network of vasculitis investigators, and participates in their clinical trials and observational studies.